NCT03819998

Brief Summary

polycystic ovary syndrome is a common gynecological problem

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 29, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

January 30, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2020

Completed
Last Updated

August 6, 2019

Status Verified

August 1, 2019

Enrollment Period

1 year

First QC Date

January 25, 2019

Last Update Submit

August 4, 2019

Conditions

Polycystic Ovary

Outcome Measures

Primary Outcomes (1)

  • The number of women who will have high level of fetuin A and has PCOS

    Evaluation of women who have PCOS in relation to fetuin A level

    within a week

Study Arms (2)

PCOS group

women who have PCOS

Diagnostic Test: measurement of Fetuin-A level in serum

control group

women who donnot have PCOS

Diagnostic Test: measurement of Fetuin-A level in serum

Interventions

measurement of Fetuin-A level in serumDIAGNOSTIC_TEST

Fetuin A level will be measured in blood of the PCOS women

Also known as: Fwtuin A level
PCOS groupcontrol group

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with polycystic ovary syndrome
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

women who have PCOS and have symptoms of hyperandrogenism and irregular cycles

You may qualify if:

  • women who have PCOS in group 1 and who donnot have PCOS in group 2 with age between 20 -42 years

You may not qualify if:

  • women above 42 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah and Kasralainy hospital

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Central Study Contacts

Mahmoud Alalfy, PhD

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2019

First Posted

January 29, 2019

Study Start

January 30, 2019

Primary Completion

February 1, 2020

Study Completion

February 5, 2020

Last Updated

August 6, 2019

Record last verified: 2019-08

Locations

EG(1)